PRTK Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.

$10.43  -0.29 (-2.71%)
As of 06/14/2021 15:59:36 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/10/2006
Outstanding shares:  46,928,028
Average volume:  612,626
Market cap:   $512,923,346
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    699374302
ISIN:        US6993743029
Sedol:      BSDHYJ0
Valuation   (See tab for details)
PE ratio:   -5.76
PB ratio:   -25.46
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy